About the Authors
- Thierry Buclin
-
* E-mail: thierry.buclin@chuv.ch
Affiliations Division of Clinical Pharmacology and Toxicology, University Hospital Center and University of Lausanne, Lausanne, Switzerland, Department of Primary Health Care, Centre for Evidence-Based Medicine, University of Oxford, Oxford, United Kingdom
- Amalio Telenti
-
Affiliation Microbiology Institute and Swiss HIV Cohort Study board, University Hospital Center and University of Lausanne, Lausanne, Switzerland
- Rafael Perera
-
Affiliation Department of Primary Health Care, Centre for Evidence-Based Medicine, University of Oxford, Oxford, United Kingdom
- Chantal Csajka
-
Affiliations Division of Clinical Pharmacology and Toxicology, University Hospital Center and University of Lausanne, Lausanne, Switzerland, Clinical Pharmacy Unit, Department of Pharmaceutical Sciences, University of Geneva and Lausanne, Lausanne, Switzerland
- Hansjakob Furrer
-
Affiliation University Clinic for Infectious Diseases and Swiss HIV Cohort Study Board, University Hospital and University of Bern, Bern, Switzerland
- Jeffrey K. Aronson
-
Affiliation Department of Primary Health Care, Centre for Evidence-Based Medicine, University of Oxford, Oxford, United Kingdom
- Paul P. Glasziou
-
Affiliation Department of Primary Health Care, Centre for Evidence-Based Medicine, University of Oxford, Oxford, United Kingdom
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: TB AT CC. Performed the experiments: TB PG. Analyzed the data: TB PG RP. Contributed reagents/materials/analysis tools: AT HF. Wrote the paper: TB JA PG. Logistic support: PG RP.